SINGAPORE, Oct. 16, 2023 — AFFiNE proved that 10k GitHub stars could be obtained in 43 days. The company said today it has raised $8 million in Series Pre-A funding bringing its total value to nearly $40 million.

AFFiNE (https://affine.pro/) made waves in the SaaS world with its impressive debut on GitHub in August 2022. The launch of its multi-model blocks, which seamlessly integrate text, database, and whiteboard, was a game-changer that immediately caught users’ attention spanning over 100 countries. With its powerful features, AFFiNE confidently promises to revolutionize the way users write, plan, and present their ideas, eliminating the need for toggling between different collaboration tools. AFFiNE is the ultimate all-in-one solution that is set to transform the way people work.

Compared with similar companies, AFFiNE achieved greater popularity in a shorter time. Within 43 days since its first launch, AFFiNE has achieved a staggering 10,000 GitHub Stars, setting a new record for the fastest growth ever achieved on the platform. With the constant release of updated versions, AFFiNE has surpassed 20,000 GitHub Stars, cementing its position as one of the most promising collaborative tools on the market. Additionally, AFFiNE has been featured on GitHub Trending an impressive 28 times in 2022, demonstrating its exceptional potential to the world.

“AFFiNE’s ambitions and hard work never stop. We will release our ultimate platform and engine for web applications including back-end and front-end infrastructure. Small and medium teams can use our platform to release a productivity web app easily.” said by AFFiNE’s founder Jiachen He (https://www.linkedin.com/in/jiachen-he-8b0740127/), “Mature infrastructure means a lot for the prosperity of an industry. Today, the web industry needs next-gen infra urgently.”

AFFiNE has been proven to be successful by the world-wide users. Now, AFFiNE can share the underlying technical capabilities with all collaborative tools and become the generally accepted developing platform and engine.

AFFiNE is the best practice and joint-development partner of Yjs, which is the most powerful CRDTs framework. AFFiNE will never stop exploring and innovating.

Based on the brilliant performance in various open-source communities, AFFiNE has successfully raised a total of $10 million in funding over three rounds. The Series Pre-A was co- led by Redpoint Ventures, Sinovation Ventures, and CGC Ventures and followed by MiraclePlus (formerly Y Combinator China), with four investors participating.

Recently, AFFiNE announced its new financing plan in a Series A round for product development and commercial operations. The company’s stellar performance in various global open-source platforms has attracted the interest of several renowned investors, who are excited to explore opportunities to invest in AFFiNE.

Media Contact: Yipei Wei (COO, Co-Founder)
Email:  [email protected]
Official Website: https://affine.pro/
Github: https://github.com/toeverything

SOURCE AFFiNE

HONG KONG, Oct. 16, 2023 — OKX Ventures, the investment arm of leading crypto exchange and Web3 technology company OKX, today announced its participation in Celestia Lab‘s Series B funding round.

Celestia is the first modular blockchain network, meaning developers can use Celestia as a base layer for consensus and data functions, and then choose a virtual machine, such as Ethereum, Solana, zero-knowledge roll-ups or any other compatible smart contract execution layers, to build and deploy their own new blockchain. This contrasts with previous generations of blockchain infrastructure, in which Layer-1 chains perform consensus, data functions and execution altogether – a structure Celestia calls ‘monolithic.’

Celestia is also expected to be the first blockchain network to use Data Availability Sampling (DAS) when it goes live later this year. DAS is a lighter, faster way to verify blocks without requiring nodes to download all the data in a block. By allowing nodes to verify smaller, randomly selected data within a block, Celestia intends to avoid the scalability tradeoffs which have historically held back Layer-1s to date.

OKX Ventures Founder Dora Yue said: “For the sake of scalability, we see a trend towards modularity in the blockchain industry. Celestia has pioneered a modular approach that is a completely different paradigm when compared to traditional Layer-1 chains, giving developers greater customization capabilities and potentially leading blockchain infrastructure into a new era.”

Developers can receive several benefits by using Celestia as a base layer for deploying modular blockchains. These benefits include higher scalability, shared security for interoperability between apps, and the flexibility to choose between execution environments including Ethereum and Solana.

To learn more about Celestia, click here.

For further information, please contact: [email protected]

About OKX Ventures

OKX Ventures is the investment arm of leading crypto exchange and Web3 technology company OKX, with an initial capital commitment of USD 100 million. It focuses on exploring the best blockchain projects on a global scale, supporting cutting-edge blockchain technology innovation, promoting the healthy development of the global blockchain industry, and investing in long-term structural value.

Through its commitment to supporting entrepreneurs who contribute to the development of the blockchain industry, OKX Ventures helps build innovative companies and brings global resources and historical experience to blockchain projects.

Find out more about OKX Ventures here.

About OKX

OKX is a world-leading technology company building the future of Web3. Known as one of the fastest and most reliable crypto trading platforms for traders everywhere, OKX’s crypto exchange is the second largest globally by trading volume and is trusted by more than 50 million users.

OKX’s leading self-custody solutions include the Web3-compatible OKX Wallet, which allows users greater control of their assets while expanding access to DEXs, NFT marketplaces, DeFi, GameFi and thousands of dApps.

OKX partners with a number of the world’s top brands and athletes, including: English Premier League champions Manchester City F.C., McLaren Formula 1, The Tribeca Festival, golfer Ian Poulter, Olympian Scotty James, and F1 driver Daniel Ricciardo.

OKX is committed to transparency and security and publishes its Proof of Reserves on a monthly basis.

To learn more about OKX visit: okx.com

Disclaimer

THIS ANNOUNCEMENT IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY. IT IS NOT INTENDED TO PROVIDE ANY INVESTMENT, TAX, OR LEGAL ADVICE, NOR SHOULD IT BE CONSIDERED AN OFFER TO PURCHASE, SELL, OR HOLD DIGITAL ASSETS. DIGITAL ASSETS, INCLUDING STABLECOINS, INVOLVE A HIGH DEGREE OF RISK, CAN FLUCTUATE GREATLY, AND CAN EVEN BECOME WORTHLESS. OKX IS NOT REGULATED BY THE FCA, THUS, PROTECTIONS SUCH AS THE FINANCIAL OMBUDSMAN SERVICE OR FINANCIAL SERVICES COMPENSATION SCHEME WILL NOT BE AVAILABLE. YOU SHOULD CONSIDER WHETHER YOU UNDERSTAND HOW CRYPTO WORKS AND WHETHER TRADING OR HOLDING DIGITAL ASSETS IS SUITABLE FOR YOU IN LIGHT OF YOUR FINANCIAL CONDITION. THE VALUE OF YOUR DIGITAL ASSETS, INCLUDING STABLECOINS, CAN INCREASE OR DECREASE AND PROFITS MAY BE SUBJECT TO CAPITAL GAINS TAX. PAST PERFORMANCE DOES NOT INDICATE FUTURE RESULTS. PLEASE CONSULT YOUR LEGAL/TAX/INVESTMENT PROFESSIONAL FOR QUESTIONS ABOUT YOUR SPECIFIC CIRCUMSTANCES.

SOURCE OKX Ventures

NORWALK, Conn., Oct. 13, 2023 — LifeSpan Vision Ventures, a venture capital firm dedicated to advancing the field of longevity biotech, is proud to announce the closing of its seventh investment, marking another significant step towards its mission of extending healthspan.

The newest addition to LifeSpan’s portfolio is Rejuvenation Technologies, who use lipid nanoparticles to deliver telomerase mRNA to restore telomere length and tissue regenerative capacity. This latest partnership underscores LifeSpan’s commitment to identifying and supporting companies that are on the forefront of developing cutting-edge solutions to address the challenges of aging biology and age-related diseases.

“We are excited to unveil our seventh investment as we continue to forge ahead in the field of longevity,” said Harry Robb, Analyst at LifeSpan Vision Ventures. “Our dedication to extending healthspan and enabling a longer, healthier, more fulfilling life for all remains at the core of our mission. We believe that the companies we invest in will play a pivotal role in driving forward the next wave of biotech solutions that promise a brighter future.”

LifeSpan Vision Ventures’ recent investment in Rejuvenation Technologies is the latest addition to a series of strategic investments, closely following funding rounds for pioneering companies such as LIfT Biosciences, Deciduous Therapeutics, and Fauna Bio, with further investments poised for announcement in the forthcoming weeks.

For more information about LifeSpan Vision Ventures, please visit https://www.lifespanvisionventures.com/.

About LifeSpan Vision Ventures

LifeSpan Vision Ventures is a forward-thinking venture capital firm specializing in investments within the aging and longevity space. Our mission is to support and accelerate the development of innovative therapies that extend healthspan, improve the quality of life for individuals as they age, and address age-related challenges. Through strategic partnerships and investments, we aim to shape a future where aging is met with vitality, resilience, and endless possibilities.

Contact: Harry Robb
mob: +44 7795042764
[email protected]

Photo – https://mma.prnewswire.com/media/2247122/logevitymission.jpg

SOURCE LifeSpan Vision Ventures

Having previously secured EUR 15 Million in funding, Bobnet Group is looking to expand its retail automation solutions in the Middle East, as part of the company’s global expansion

DUBAI,UAE, Oct. 13, 2023 — European start-up Bobnet, backed by NCH Capital, announces upcoming series B of EUR 50 million funding round, to address current challenges faced by major retail chains and the technological evolution of the industry towards automation and improved logistics processes.

Bobnet has already secured EUR 15 million in previous investments and is now seeking an additional EUR 50 million to expand its solutions to the Middle East, as part of the company’s global expansion, as the region’s retail industry is fast developing and embracing technological innovations.

Leading innovator in retail technology solutions, Bobnet Group, is thrilled to make its latest regional expansion announcement at this year’s GITEX Global in Dubai, where the company is set to showcase its cutting-edge retail innovation products and unveil its recent milestones. The company has developed a breakthrough digital Chain Management System aimed at streamlining operations in the retail sector, and this new investment will enable them to offer their solutions on a global scale.

The Bobnet venture startup has been working since 2018 on a series of hardware and software automation solutions, developed to overcome problems of implementing and managing large retail chains. The company has succeeded in creating a chain of 120 automated selling food and grocery free checkout machines placed in a real- life use case market, whilst testing and optimizing its advanced hardware and software solutions, to create a fully functional management system of such retail chains.

“The Bobnet Chain Management system is the first software on the market able to conduct by itself operations for retail chains with thousands and millions of sales and logistic units, which are able to communicate with a cloud based infrastructure through IoT means. Thus, with our technology, creating a live physical retail chain, which is scattered in space and still operates as a single body in a fully automated mode, is now possible by almost fully eliminating the need for human involvement in the process.”, explains Victor Popusoi, Bobnet‘s founder.

To learn more about Bobnet Group hardware and software solutions for the retail industry firsthand, visit the company’s booth at GITEX Technology Week in Dubai, located at H9-A16. The event will take place from the 16th to the 20th of October at Dubai Harbour.

For inquiries regarding investment opportunities and partnership details, please contact:

[email protected]
+ 40766 350 466 

SOURCE Bobnet Group

BOULDER, Colo., Oct. 12, 2023 — PickNik Robotics, “The Unstructured Robotics Company,” proudly announces a major milestone in its mission to bring robot arms out of factories and into our everyday lives. The company has just raised $2 million in a pre-seed investment round led by Stellar Ventures and Cypress Growth Capital, positioning itself as the dominant force in redefining the robotics industry through its innovative software platforms. The investment augments PickNik’s existing $5M in non-dilutive SBIR funding contracts with NASA JSC, NASA Ames, and Space Force.

This funding will be used to further develop their powerful robotics platform MoveIt Studio, which enables any developer or engineer to create advanced applications with robot arms. MoveIt Studio is unique in that it tackles a new and fast-growing robotics market segment: robots outside of the traditional manufacturing domain. MoveIt Studio is already being used by many companies for advanced applications like Autonomous Mobile Robots (AMR) that leverage mobile robot arms for in-situ bin picking, explosive ordnance disposal for SWAT teams, and next-gen space applications such as autonomous cargo unloading from space station re-supply capsules.

Dave Coleman, CEO of PickNik, expressed his enthusiasm for the pre-seed investment, saying, “This investment marks a pivotal moment in our journey from a bootstrapped company that could only innovate incrementally. We’re now committed to pushing the boundaries of what’s possible with robot arms faster. With Stellar Ventures and Cypress Growth Capital by our side, we have the resources and support to fully commercialize our powerful platform that enables developers everywhere to build advanced robot arm applications with less risk.”

PickNik’s unique vision makes advanced robotics accessible through both open source and open core software. Their flagship software MoveIt Studio is built on their original, highly popular open source MoveIt software that continues to be one of the top motion planning and manipulation frameworks globally. By embracing open source principles, PickNik empowers its customers to reduce R&D costs significantly and collaborate with well known de facto standards.

PickNik consistently demonstrates its leadership tackling the most challenging problems in robotics across many industries, including space, subsea, surgical, energy, AgTech, FoodTech, and personal robots. With an unparalleled commitment to solving robotics challenges outside of factories, PickNik has earned the trust and recognition from industry giants including Google, Amazon, Johnson & Johnson, Samsung, Hyundai, NASA, Sierra Space, Blue Origin, and many more.

“The robotics industry is rapidly evolving, and PickNik is at the forefront of innovation. We see immense potential in their ability to develop advanced solutions that bridge the gap between terrestrial and space robotics,” said Matt Patterson at Stellar Ventures.

Investors are drawn to PickNik’s exceptional capabilities. Their dexterous manipulator control has earned the company praise from esteemed organizations like NASA (whose multiple SBIR programs have historically funded PickNik). “There are few others in the industry of robotics with the capability of PickNik, especially capabilities as expansive as their abilities with dexterous manipulator control,” stated a robotics engineer at NASA Johnson Space Center.

“As use cases for robotics applications become more complex, PickNik’s expertise and track record of solving the most difficult robotics problems is highly differentiated in this $230B market. With MoveIt Studio, PickNik is able to leverage that experience and deliver it to an even broader customer base.” said Pat McCaffrey, Partner at Cypress Growth Capital.

PickNik is proud to be a leader of the Robot Operating System movement. The company created ROS drivers for many popular robots used globally including Universal Robotics, Kinova, ABB, and Motiv Space Systems. As a 100% robot-arm agnostic company, PickNik works with a wide range of robot brands and types, from custom hardware to off-the-shelf solutions, catering to the specific needs of its customers.

This pre-seed investment allows PickNik to further revolutionize the unstructured robotics software space with their MoveIt Studio product, and solidify its position as an industry leader, poised for a future filled with exciting possibilities.

About PickNik Robotics:
PickNik Robotics, known as “The Unstructured Robotics Company,” is a leader in solving complex robotics challenges. The company’s flagship software, MoveIt Studio, is the world’s #1 motion planning and manipulation platform, embracing open source principles to make advanced robotics accessible and cost-effective. PickNik collaborates with a wide range of industries and has a track record of excellence in developing robotic applications while mitigating open source risks.

About Stellar Ventures:
Stellar Ventures is a forward-thinking venture capital firm that initiated its journey with the launch of SV Andromeda, a $23 million fund dedicated to supporting visionary entrepreneurs at the forefront of space technology. With a commitment to fostering innovation and transformative ideas, Stellar Ventures collaborates with exceptional founders who are poised to revolutionize industries and make a lasting impact on our world.

About Cypress Growth Capital:
Cypress Growth Capital, with a twelve-year track record and a team rich in entrepreneurial experience, goes beyond traditional investment, providing invaluable guidance to portfolio companies. They assist in shaping growth strategies, offer financial expertise, aid in talent development, and facilitate mergers, acquisitions, and exits, making them a trusted partner for entrepreneurs seeking exceptional outcomes.

SOURCE PickNik Robotics

NEW YORK, Oct. 12, 2023 — Zolve, a cross border neobank helping immigrants across the world gain access to financial services, is proud to announce that it has secured a warehouse debt facility of up $100 million from Community Investment Management (CIM). This milestone marks another significant step forward in Zolve’s mission to ensure the seamless movement of people and money across countries.

The $100 million debt fund secured from CIM will be used to cater to offering credit products to migrants in the US. This infusion of funds will enable Zolve to further empower individuals from a multitude of geographical locations and demographic backgrounds on their financial journeys, ultimately elevating their banking experience within the United States.

Since its inception in August 2021, the platform has attracted around 500,000 users, facilitating transactions worth more than $600 million. The company’s customer retention at > 86% (12 month) and the increase in organic and referral rate (now at >62%) over the last two years conveys that Zolve effectively addresses a persisting challenge faced by a substantial portion of its customer base.

“Zolve is driven by a vision of growth and inclusivity, breaking down financial barriers,” says Raghunandan G, Founder of Zolve. “I believe that when individuals embark on journeys to new countries, be it for education or work, financial barriers should never impede their progress. With the recent capital we’ve raised, we move closer to realizing a world where access to essential financial resources transcends borders and backgrounds.”

Trends Pointing to Increased Immigration to the US

Reports indicate that more than 2.5 million people immigrate to the US annually, contributing over $75 billion to the economy. Additionally, with over 45 million foreign-born residents, there is a significant opportunity to support their financial needs, including international money transfers, affordable insurance plans and loans.  “We are excited to be early supporters of Zolve’s vision to provide a comprehensive financial solution to the global immigrant community in the United States,” said Jacob Haar, Managing Partner of CIM. “In only two years of operations, Zolve has achieved remarkable growth within this creditworthy but underserved segment of the market and we are pleased to partner with Raghunandan and his team.”

The Road Ahead for Zolve

“Zolve has achieved remarkable growth within only two years of operations while ensuring profitable unit economics amidst a challenging global macro environment” says Anand Daniel, Partner at Accel, one of Zolve’s early investors.

With this new infusion of funds, Zolve is poised for further expansion. Geographically, UK, Canada and Australia top the list, given its popularity among global immigrants. Raghunandan G, further adds, “In the quarters ahead, we’re set to broaden our horizons. Our journey has just begun, and we aspire to extend our reach, offering a bouquet of inclusive financial services that elevate the financial experience for all.”

Zolve is a financial technology company, not a bank. The Zolve Debit Card, and Zolve Credit Card, and Zolve Azpire Credit Card are issued by Community Federal Savings Bank, Member FDIC and the Zolve account is offered by Community Federal Savings Bank. In February 2021, Zolve raised $15 Million in seed funding, led by Accel and Lightspeed followed by $40 Million raise in October 2021

Community Investment Management (CIM) is an institutional impact investment manager that provides strategic debt capital to demonstrate and scale responsible innovation in lending. CIM is dedicated to supporting organizations that drive positive change and foster financial inclusion, economic growth, and social impact. Visit https://cim-llc.com/

Photo – https://mma.prnewswire.com/media/2245818/Zolve.jpg
Logo – https://mma.prnewswire.com/media/2245816/Zolve_Logo.jpg

SOURCE Zolve

• New academic research awards to be jointly selected and funded in the field of cancer cell–extrinsic tumor dependencies, potentially creating novel therapeutics.
• Pioneering pharma/non-profit alliance allows pooling of both organizations’ expertise and resources in this emerging research area and commercialization of the most promising discoveries, including the possible creation and funding of spin-out companies.

NEW YORK, Oct. 12, 2023 — The Mark Foundation for Cancer Research today announced an alliance with Takeda to accelerate the discovery and development of novel treatments for cancer. The unique approach leverages The Mark Foundation’s global network of leading academic scientists and robust project review and funding platform, as well as Takeda’s extensive track record of developing life-saving cancer treatments. The alliance will spearhead an emerging area of research: advancing the understanding and development of treatments targeting ancillary cell types that collude with cancer cells in tumor formation and progression.

The Mark Foundation will receive financial support from Takeda to launch an exclusive workshop and co-fund external research projects. The scientific workshop will bring together hand-picked scientists from different disciplines to dream up novel approaches for suppressing the supportive environment that allows tumors to thrive. These scientists, and potentially others, will be invited to apply for academic research funding to initiate research on the exceptional approaches developed.

“The past two decades have demonstrated the power of using a precision medicine approach to target specific vulnerabilities within the cancer cell itself,” noted Ryan Schoenfeld, CEO of The Mark Foundation. “Through this collaboration, Takeda and The Mark Foundation have committed to pushing the boundaries by targeting the unique dependencies between the tumor biology and the multitude of stromal and immune cell types that support tumorigenesis, with the goal of turning transformative discoveries into life-changing therapies for patients. Takeda is the ideal partner for our first alliance with a pharmaceutical company, with their deep scientific expertise and commitment to external innovation. When exciting discoveries arise from these research projects, we will have a partner on board to help dramatically accelerate these innovations to reach patients.”

“Current therapies targeting the tumor, tumor microenvironment and the immune response are just the tip of the iceberg,” said Kathy Seidl, head of Takeda’s Oncology Drug Discovery Unit. “We are thrilled to work with The Mark Foundation and their network of top cancer researchers, some of whom are already on the road to validating novel targets in this emerging cross-section of cancer biology and the tumor microenvironment. The Mark Foundation’s expertise in attracting and reviewing cutting-edge proposals gives them a compass pointing toward the next big breakthroughs in cancer therapeutics. Our missions are shared: to advance innovative academic discoveries from the bench to patient impact.”

Takeda and The Mark Foundation have established joint governance of the alliance that will allow for a hands-on approach to supporting projects and their commercialization, including the possible creation and funding of spin-out companies. Sacha Mann, Senior Investment Director and Partner at Takeda Ventures, Inc., Adnan Abu-Yousif, Senior Director and Head of Cold-to-Hot Biology in Takeda’s Oncology Drug Discovery Unit, Becky Bish, Head of Discovery and Preclinical Research at The Mark Foundation, and Anna Turetsky, Principal, Venture Investments at The Mark Foundation serve on the alliance board.

About The Mark Foundation for Cancer Research

The Mark Foundation for Cancer Research, a charitable organization based in New York City, actively partners with scientists around the world to accelerate research that will transform the prevention, diagnosis, and treatment of cancer. Since 2017, The Mark Foundation has awarded more than $200 million in grants to over 100 academic institutions across 13 countries, with research programs focusing on early career support, team science collaboration, new technology innovation, and therapeutics discovery. Additionally, The Mark Foundation maintains a growing portfolio of investments in early-stage cancer diagnostics and therapeutics companies, including several that have transitioned from grantee projects into commercial development. To learn more please visit www.TheMarkFoundation.org.

Contact:
Linda Heaney
[email protected]

SOURCE The Mark Foundation for Cancer Research

Dedicated to Fostering the Next Generation of Emerging Breakout Beverage Brands 

LOS ANGELES, Oct. 12, 2023 — Alethia Venture Partners is pleased to announce the launch of their $50 million debut fund, Alethia Opportunity Fund I. The venture fund is actively deploying capital into the next wave of growth brands across the wider beverage category.

Alethia VP partners with exceptional founders building differentiated brands and products, with a clear path to scale and exit. Growth capital will be used to support sales, marketing, distribution, and logistics needed to scale. 

Mike Warren, Founder and Managing Partner of Alethia Venture Partners states, “We couldn’t be more excited at the possibilities ahead – now is the time to take a leading position across some of the most exciting opportunities within beverage. We’ve put together the best team to help propel these brands to the next level in 2023 and beyond.”

Alethia plans to make approximately 15-20 beverage investments ranging from $250,000 to $5 million, and the fund will seek to lead and co-lead series seed, A, and B financing rounds.

The fund is comprised of experienced operators, bankers, current and former C-level executives, and investors, including Brian Stolz, Logan Zinser, Bob Frady and Taylor Foxman. The team has achieved multiple exits over three decades and have operated and advised Fortune 50-1000 companies. Initial investments will be announced later this year.

To learn more visit https://alethiavp.com/  or email [email protected].

Communications Contact
Taylor Foxman
609-432-2237
[email protected]

Legal Disclaimer: This press release is for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation for any security, nor does it constitute an offer to provide investment advisory or other services. Past performance is not indicative of future results.

SOURCE Alethia Ventures

$2.5M in additional funding brings Series A total to $7M and will further support product development and team scaling

INDIANAPOLIS, Oct. 12, 2023 — Prevounce Health, a leading provider of remote care management software, devices, and services, today announced the closing of $2.5 million in new Series A funding led by Cloud Hill Partners and Michael Hammond, former co-founder of Hammond Hanlon Camp LLC and H2C Securities, with participation from additional returning investors. The company has now raised $7 million in total Series A funding and will use the latest financing to advance its product and service offerings and scale its team to meet growing market demand.

Prevounce offers a comprehensive, cloud-based remote care management platform, proprietary cellularly connected patient devices, and expert managed services that empower efficient and effective remote patient monitoring (RPM), chronic care management (CCM), and wellness programs. Practice, health system, and payor clients benefit from Prevounce’s deep healthcare compliance and operational expertise, as well as its full-service device shipping and logistics support. Prevounce tailors RPM solutions, including any combination of software, custom devices, care services, and logistics, to meet specific client business and patient outcome goals.

“Remote preventive and chronic care services have a demonstrated ability to improve patient outcomes and increase practice revenue. Yet, the potential of these services often isn’t realized due to significant regulatory complexity and administrative burden,” says Daniel Tashnek, Founder and CEO of Prevounce Health. “We’re thrilled to see continued interest in advancing Prevounce’s mission to enable healthcare organizations of all sizes to implement comprehensive remote care programs that make connected health easy for patients and providers.”

Launched in 2019 by physicians, practice managers, and healthcare attorneys, Prevounce now has more than 450 healthcare organizations using its products to manage over 26,000 patients across the country with a variety of conditions, including hypertension, heart failure, diabetes, COPD, and preeclampsia. Both device agnostic and a data aggregator, Prevounce software connects to hundreds of third-party technology platforms and devices through integrations and APIs. 3.5 million vitals device readings have entered the Prevounce platform since launch.

“This is an exciting time as organizations across the healthcare continuum are recognizing a dire need to refocus how providers interact with their patients,” said Hammond, who also serves as Chairman of Prevounce Health. “We’ve seen fantastic growth at Prevounce. With this latest round of financing and exciting, new strategic partners and clients, we’re poised to remain the best partner for healthcare organizations building large scale remote care initiatives.”

About Prevounce Health

Prevounce Health helps simplify the provision of remote patient monitoring, chronic care management, preventive care, and annual wellness visits while ensuring compliance with regulatory and reimbursement guidelines. Prevounce provides resources and support that are custom-tailored to clients’ needs, allowing them to focus on providing good care to patients while reducing time spent on tedious paperwork. Prevounce’s goal is to allow provider organizations of all sizes to implement comprehensive patient wellness programs that increase their practice revenue, patient engagement, and clinical staff efficiency. Learn more at www.prevounce.com.

Media Contact:
Casey Johnson
(818) 253-8755
[email protected]

SOURCE Prevounce Health